01 — Financials
Financial overview
Revenue
NOK 733,712
Period ending 2024-12-31
Operating profit
NOK 144,443
Profit before tax
NOK 150,170
Net profit
NOK 116,630
Total assets
NOK 827,222
Equity
NOK 512,032
Latest reporting period ending 2024-12-31
02 — Signals & news
Recent activity
No signals tracked yet
Funding rounds, hiring activity, and leadership changes will appear here when detected
Set up alerts for this company
Get notified about funding, hiring, and leadership changes
03 — Get in touch
Reach ELEXIR PHARMA CAPITAL NORGE NUF
Key people
Heidi Månsson
Daglig leder
Draft an intro emailpro
AI-generated contextual outreach
Prepare a meeting briefpro
One-page summary for your next call
Find decision-makerspro
Search by role and seniority
04 — Similar companies
Companies like ELEXIR PHARMA CAPITAL NORGE NUF
Similar company matching coming soon
We're building AI-powered matching based on industry, size, location, and business model
Discover companies in our directory
Search >100,000 Nordic companies by name, industry, or location
Get the full picture on ELEXIR PHARMA CAPITAL NORGE NUF
Financial history, alerts, outreach tools, and more. Free to use within limits.
Sign up free